ALKS vs MSCI · P/E 14, rev $1.56B vs P/E 37, rev $2.86B
Alkermes Plc (ALKS) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported MSCI revenue for 2024-12-31 was $2.86B. Net income was $1.11B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the ALKS and MSCI stock pages for the full models.
Not investment advice.